
    
      During cycle I (chemoradiation), gemcitabine (200 mg/m2) and cetuximab 400mg/m2 initial dose
      followed by 250mg/m2 IV weekly will be given with continuous infusion 5-FU (200 mg/m2/day)
      delivered 5 of every 7 days and concurrent external beam radiation therapy. Cetuximab,
      gemcitabine and 5-FU will begin on the first week of external beam radiotherapy and will
      continue throughout the course of external beam radiation therapy, and will be discontinued
      following the conclusion of external beam radiation therapy. All patients will have a central
      venous access device placed to facilitate chemotherapy administration.

      During cycles 2 through 5 (chemotherapy), gemcitabine will be administered at a dose of 1000
      mg/m2 over 30 minutes followed by cetuximab at a dose of 250mg/m2 over 30 minutes weekly for
      3 weeks followed by one-week rest for four cycles.
    
  